BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//UM//UM*Events//EN
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:America/Detroit
TZURL:http://tzurl.org/zoneinfo/America/Detroit
X-LIC-LOCATION:America/Detroit
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20070311T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20071104T020000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTAMP:20251114T080452
DTSTART;TZID=America/Detroit:20260210T160000
DTEND;TZID=America/Detroit:20260210T170000
SUMMARY:Lecture / Discussion:CPOD Winter 2026 Seminar Series: \"When red cells talk to bone ‒ Crosstalk mechanisms in musculoskeletal disorders\"
DESCRIPTION:Annemarie Lang\, D.V.M.\, Ph.D.\nAssistant Professor\nOrthopaedic Surgery\nUniversity of Michigan
UID:141862-21889543@events.umich.edu
URL:https://events.umich.edu/event/141862
CLASS:PUBLIC
STATUS:CONFIRMED
CATEGORIES:biomedical engineering
LOCATION:Taubman Biomedical Science Research Building - ABC Seminar Rooms
CONTACT:
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20260204T104352
DTSTART;TZID=America/Detroit:20260212T150000
DTEND;TZID=America/Detroit:20260212T160000
SUMMARY:Workshop / Seminar:Biomedical Engineering (BME 500) Seminar Series
DESCRIPTION:From Concept to Care: Leading R&D and Operations in the Medical Device Industry\nAbstract:\nThis seminar focuses on the career journey and real-world experiences of a Vice President of R&D and Operations Engineering in the medical device industry. Students will gain insight into how careers evolve across engineering\, innovation\, operations\, and leadership\, and what skills\, mindsets\, and decisions enable long-term success. The session offers practical guidance on navigating industry roles\, learning from early career choices\, and building a path at the intersection of engineering\, healthcare\, and business impact.\n\nBio:\nWith more than 25 years in the medical device industry\, Carlos M. Ortega (Vice President of R&D and Operations Engineering) has built a career at the intersection of innovation\, engineering execution\, and clinical impact. Having held leadership and functional roles at companies such as Terumo\, Medtronic\, and Johnson & Johnson\, he has contributed to the development and commercialization of technologies across cardiovascular\, neurovascular\, aortic\, and peripheral vascular therapies.\n\nHis experience spans predominantly R&D leadership\, complemented by roles in operations engineering and product marketing\, giving him a unique perspective on how ideas translate into manufacturable\, clinically meaningful products. Throughout his career\, he has led multidisciplinary teams\, navigated complex regulatory environments\, and helped organizations align technology development with patient and business needs.\n\nHe is passionate about the impact medical devices have on the lives or the patients they serve and in mentoring the next generation of professionals by sharing practical insights into building impactful careers in the medical device industry.
UID:145043-21896577@events.umich.edu
URL:https://events.umich.edu/event/145043
CLASS:PUBLIC
STATUS:CONFIRMED
CATEGORIES:biomedical engineering
LOCATION:Lurie Biomedical Engineering (formerly ATL) - 1130
CONTACT:
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20260202T132529
DTSTART;TZID=America/Detroit:20260217T100000
DTEND;TZID=America/Detroit:20260217T110000
SUMMARY:Livestream / Virtual:Careers in the Biosciences (Virtual Panel)
DESCRIPTION:University of Michigan staff discuss their career paths\, including graduate/medical training\, academic/industry research\, consulting\, and teaching.\n\nVirtual panel - RSVP for link: https://linktr.ee/FIRST_Org\n\nPanelists:\nDr. Zie Craig\, PhD\nDr. Emma Thornton-Kolbe\, PhD\nDr. Chris Ting\, MD
UID:144925-21896158@events.umich.edu
URL:https://events.umich.edu/event/144925
CLASS:PUBLIC
STATUS:CONFIRMED
CATEGORIES:Biomedical Engineering
LOCATION:Off Campus Location
CONTACT:
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20260106T103655
DTSTART;TZID=America/Detroit:20260219T120000
DTEND;TZID=America/Detroit:20260219T130000
SUMMARY:Workshop / Seminar:DCMB Tools and Technology Seminar by Mukai Wang
DESCRIPTION:Abstract\nMicrobiome differential abundance analysis remains a challenging problem despite multiple methods proposed in the literature. The excessive zeros and compositionality of metagenomics data are two main challenges for differential abundance analysis. We propose a novel method called “analysis of differential abundance by pooling Tobit models” (ADAPT) to overcome these two challenges. ADAPT uniquely treats zero counts as left-censored observations to facilitate computation and enhance interpretation. ADAPT also encompasses a theoretically justified way of selecting non-differentially abundant microbiome taxa as a reference for hypothesis testing. We generate synthetic data using independent simulation frameworks to show that ADAPT has more consistent false discovery rate control and higher statistical power than competitors. We use ADAPT to analyze 16S rRNA sequencing of saliva samples and shotgun metagenomics sequencing of plaque samples collected from infants in the COHRA2 study. The results provide novel insights into the association between the oral microbiome and early childhood dental caries.\n\nAbout the DCMB Tools & Technology Seminar Series\n\nThe DCMB Tools and Technology Seminar Series is held in Medical Science Building 1 (MS1)\, Room 4B700\, each Thursday at 12pm EST. Each seminar highlights a computational tool\, technology\, or methodology that is under development or in current use and is of special interest to DCMB and University researchers. Presenters are U-M researchers and students.\n\nThese seminars are live-streamed and recorded and made available for future viewing via the DCMB YouTube ChannelAbout the DCMB Tools & Technology Seminar Series\n\nThe DCMB Tools and Technology Seminar Series is held in Medical Science Building 1 (MS1)\, Room 4B700\, each Thursday at 12pm EST. Each seminar highlights a computational tool\, technology\, or methodology that is under development or in current use and is of special interest to DCMB and University researchers. Presenters are U-M researchers and students.\n\nThese seminars are live-streamed and recorded and made available for future viewing via the DCMB YouTube Channel
UID:143260-21892595@events.umich.edu
URL:https://events.umich.edu/event/143260
CLASS:PUBLIC
STATUS:CONFIRMED
CATEGORIES:Biomedical Engineering
LOCATION:Medical Science Unit I - Room 4B700
CONTACT:
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20260210T142826
DTSTART;TZID=America/Detroit:20260219T150000
DTEND;TZID=America/Detroit:20260219T160000
SUMMARY:Workshop / Seminar:Biomedical Engineering (BME 500) Seminar Series
DESCRIPTION:Advancing Ultrasound Therapy and Imaging: Towards High-Precision\, Real-time Solutions\n\nAbstract:\nAchieving high-precision diagnosis and therapy with ultrasound is challenging due to the heterogeneous nature of biological tissues. This seminar will present recent technological advances in ultrasound to improve both imaging performance and therapeutic capability.\n\nThe first part of the seminar will introduce transcranial histotripsy as a non-invasive brain therapy. Histotripsy is a non-thermal\, non-ionizing ultrasound therapy that mechanically fractionates target tissue through acoustic cavitation generated by short\, high-intensity ultrasound pulses. Transcranial histotripsy is particularly challenging because the intact human skull introduces severe attenuation and phase aberration. This seminar will discuss the specialized instrumentation for transcranial histotripsy\, methods to ensure precise targeting and real-time monitoring (including skull aberration correction and cavitation imaging)\, and feasibility and safety evaluation of transcranial histotripsy in preclinical studies.\n\nThe second half of the seminar will focus on ultrafast ultrasound imaging using large-aperture arrays. By combining ultrafast acquisition techniques with parallel computing\, this approach enables high-resolution volumetric imaging over a large field of view at video-rate frame rates. Two clinically relevant applications will be presented: panoramic spine imaging for diagnosis and interventional guidance\, and breast ultrasound tomography for early cancer screening. Finally\, we will discuss remaining technical challenges for clinical translation and highlight how advances in ultrafast imaging can be integrated with histotripsy to enable safer\, more precise therapies.\n\nBio:\nDr. Ning Lu is a Senior Ultrasound Engineer at United Imaging Healthcare North America in Bellevue\, Washington. She completed her postdoctoral training in the Department of Radiology at Stanford University under the mentorship of Prof. Katherine W. Ferrara\, where she developed high-resolution 3D ultrasound imaging techniques for diagnostic and interventional guidance. Dr. Lu received her Ph.D. in Biomedical Engineering and Scientific Computing (joint degree) from the University of Michigan in 2023\, working with Prof. Zhen Xu on MR-guided transcranial histotripsy for non-invasive brain therapy. Her research interests include biomedical ultrasound\, medical instrumentation\, parallel computing\, and AI-driven imaging science. Her long-term career goal is to develop high-precision\, affordable\, personalized ultrasound solutions for therapy\, diagnosis\, and health monitoring.
UID:145330-21897104@events.umich.edu
URL:https://events.umich.edu/event/145330
CLASS:PUBLIC
STATUS:CONFIRMED
CATEGORIES:biomedical engineering
LOCATION:Lurie Biomedical Engineering (formerly ATL) - 1130
CONTACT:
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20251114T080730
DTSTART;TZID=America/Detroit:20260224T160000
DTEND;TZID=America/Detroit:20260224T170000
SUMMARY:Lecture / Discussion:CPOD Winter 2026 Seminar Series: \"How cells force the gut into shape\"
DESCRIPTION:Tyler Huycke\, Ph.D.\nAssistant Professor\nMolecular\, Cellular\, & Developmental Biology\nUniversity of Michigan
UID:141863-21889544@events.umich.edu
URL:https://events.umich.edu/event/141863
CLASS:PUBLIC
STATUS:CONFIRMED
CATEGORIES:biomedical engineering
LOCATION:Taubman Biomedical Science Research Building - ABC Seminar Rooms
CONTACT:
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20260129T164237
DTSTART;TZID=America/Detroit:20260225T120000
DTEND;TZID=America/Detroit:20260225T133000
SUMMARY:Livestream / Virtual:Building Industry Partnerships Webinar Series
DESCRIPTION:Federal funding trends\, including from NSF\, DOE and ARPA agencies\, indicate increasing interest in translational research – supporting the pathways for fundamental discoveries to have broader societal\, economic or public impact. New funding programs might require researchers to demonstrate their research impact at the proposal stage through established partnerships with companies that signal market interest or investment\, formal commitments like licensing agreements\, and/or evidence of technology readiness levels. Researchers who build these industry partnerships in advance will have a critical edge in a competitive funding landscape.\n\nThe Office of Research Development will host a webinar series for U-M researchers that explains why and how to build industry partnerships that advance mutual R&D goals. Webinars will take place noon-1:30 pm each day\; calendar invites will be sent upon registration. \n\nFebruary 25: Discovery to Innovation - Gain a practical framework for deciding when to engage industry\, how to demonstrate impact credibly and which funding mechanisms align with research maturing and scholarly goals.\nMarch 26: Industry Engagement for Faculty: From Early Signals to Funded Partnerships - Learn meaningful engagement strategies across the research lifecycle\, emphasizing alignment with academic incentives\, research integrity and appropriate funding mechanisms. \nApril 9: Building Industry Partnerships that Last: Whom to Talk to\, What to Ask - Learn how to identify the right industry counterparts\, structure early conversations to surface meaningful research and translational opportunities and set expectations that can evolve into sustained collaboration.   \nContact RD-Support@umich.edu with questions.
UID:144802-21895959@events.umich.edu
URL:https://events.umich.edu/event/144802
CLASS:PUBLIC
STATUS:CONFIRMED
CATEGORIES:Biomedical Engineering
LOCATION:Off Campus Location
CONTACT:
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20260211T085633
DTSTART;TZID=America/Detroit:20260226T150000
DTEND;TZID=America/Detroit:20260226T160000
SUMMARY:Workshop / Seminar:Biomedical Engineering (BME 500) Seminar Series
DESCRIPTION:Cellular Mechanisms of Vascular Calcification and Opportunities for Targeted Therapies\n\nAbstract:\nVascular calcification is the major precursor to cardiovascular disease and is further exacerbated by chronic kidney disease. Phosphate is a known precursor to vascular calcification which leads to the onset of CVCs and other complications. Increased serum levels of inorganic phosphate lead to calcification of vascular smooth muscle cells and a phenotypic switch to an osteoblast-like cell. Once thought to be a passive process of calcium and phosphate deposition within arteries\, vascular calcification is now known to be an active\, cell-regulated condition. There is a clinical need to develop a therapy for vascular calcification that reduces calcification without causing arterial damage similar to current therapies such as endovascular stent and atherectomy. We are examining the role of phosphate in vascular smooth muscle cell calcification and the potential of protein therapy to reduce calcification.\n\nBio: \nDr. C. LaShan Simpson Hendrix is an Associate Professor in the Department of Biomedical Engineering at the University of Cincinnati. Before joining the faculty at University of Cincinnati in 2024\, she was an Associate Professor at Mississippi State University (2013 – 2023) and she trained as a postdoctoral research associate at Rice University in the Department of Bioengineering. Dr. Hendrix received all her educational training at Clemson University with a B.S. in Biochemistry\, M.S.\, and Ph.D. In Bioengineering. Dr. Hendrix’s research interests include vascular calcification\, smooth muscle cells\, cell and gene therapy\, and mechanotransduction. Her work has been funded by the National Science Foundation (NSF)\, the National Institutes of Health (NIH)\, and the United States Department of Agriculture (USDA).\n\nIn addition to her passion for vascular research\, Dr. Hendrix is a student advocate and a champion for diversity and inclusion. She has worked to create inclusive spaces for trainee development and success. She has received numerous awards for her efforts including Teacher of the Year\, College of Agriculture and Life Sciences at Mississippi State University\, 2018\; Academy of Distinguished Teachers\, Bagley College of Engineering at Mississippi State University\, 2019\; and Excellence in Diversity and Inclusion Award\, Mississippi Institute of Higher Learning\, 2020. Her pride and joy are the diversity of her research lab and the outstanding accomplishments of her trainees. Dr. Hendrix is the founder of BlackWomenInBME and has hosted sessions for her group at the Biomedical Engineering Society (BMES) Annual meeting since 2018. She is the recipient of the 2021 Biomedical Engineering Society Diversity Award Lecture and the 2025 Mentor Award from the American Association for the Advancement of Science (AAAS).
UID:145355-21897164@events.umich.edu
URL:https://events.umich.edu/event/145355
CLASS:PUBLIC
STATUS:CONFIRMED
CATEGORIES:biomedical engineering
LOCATION:Lurie Biomedical Engineering (formerly ATL) - 1130
CONTACT:
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20260212T194436
DTSTART;TZID=America/Detroit:20260306T080000
DTEND;TZID=America/Detroit:20260306T170000
SUMMARY:Conference / Symposium:10th Annual RNA Symposium
DESCRIPTION:The Center for RNA Biomedicine at the University of Michigan proudly invites you to the 2026 RNA Symposium\, convening thought leaders and pioneering researchers in the field of RNA science and biomedicine.\n\nFriday\, March 6\, 2026\nSaturday\, March 7\, 2026\n\nRNA Frontiers: From Mechanisms to Medicine\n\nThis year’s symposium explores the dynamic world of RNA\, highlighting how fundamental mechanisms and molecular machines are shaping both our understanding of cellular processes and the development of next-generation medical innovations. Through cutting-edge scientific talks and a patient advocacy panel discussion\, we will explore a wide range of topics spanning epigenetics\, genome editing\, RNA structure\, and translational research\, and discover together how RNA is propelling biological discovery from molecular intricacy to real-world impact in medicine and beyond.\n\nScheduled Speakers:\n\nShelley Berger\, Ph.D.\nUniversity of Pennsylvania\n\nKarla Neugebauer\, Ph.D.\nYale School of Medicine\n\nMadeleine Oudin\, Ph.D.\nTufts University\n\nErik Sontheimer\, Ph.D.\nUMass Chan Medical School\n\nNils Walter\, Ph.D.\nUniversity of Michigan\n\nSarah Woodson\, Ph.D.\nJohns Hopkins University\n\nOnline registration ends Friday\, February 20! SPACE IS LIMITED - Register Today! \n\n➡️ Open call for U-M student volunteers who will receive complimentary registration. Email Center Manager Paul Avedisian at paulave@umich.edu for more details!
UID:136482-21878770@events.umich.edu
URL:https://events.umich.edu/event/136482
CLASS:PUBLIC
STATUS:CONFIRMED
CATEGORIES:Biomedical Engineering
LOCATION:Taubman Biomedical Science Research Building - Kahn Auditorium
CONTACT:
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20260212T194436
DTSTART;TZID=America/Detroit:20260307T080000
DTEND;TZID=America/Detroit:20260307T170000
SUMMARY:Conference / Symposium:10th Annual RNA Symposium
DESCRIPTION:The Center for RNA Biomedicine at the University of Michigan proudly invites you to the 2026 RNA Symposium\, convening thought leaders and pioneering researchers in the field of RNA science and biomedicine.\n\nFriday\, March 6\, 2026\nSaturday\, March 7\, 2026\n\nRNA Frontiers: From Mechanisms to Medicine\n\nThis year’s symposium explores the dynamic world of RNA\, highlighting how fundamental mechanisms and molecular machines are shaping both our understanding of cellular processes and the development of next-generation medical innovations. Through cutting-edge scientific talks and a patient advocacy panel discussion\, we will explore a wide range of topics spanning epigenetics\, genome editing\, RNA structure\, and translational research\, and discover together how RNA is propelling biological discovery from molecular intricacy to real-world impact in medicine and beyond.\n\nScheduled Speakers:\n\nShelley Berger\, Ph.D.\nUniversity of Pennsylvania\n\nKarla Neugebauer\, Ph.D.\nYale School of Medicine\n\nMadeleine Oudin\, Ph.D.\nTufts University\n\nErik Sontheimer\, Ph.D.\nUMass Chan Medical School\n\nNils Walter\, Ph.D.\nUniversity of Michigan\n\nSarah Woodson\, Ph.D.\nJohns Hopkins University\n\nOnline registration ends Friday\, February 20! SPACE IS LIMITED - Register Today! \n\n➡️ Open call for U-M student volunteers who will receive complimentary registration. Email Center Manager Paul Avedisian at paulave@umich.edu for more details!
UID:136482-21878771@events.umich.edu
URL:https://events.umich.edu/event/136482
CLASS:PUBLIC
STATUS:CONFIRMED
CATEGORIES:Biomedical Engineering
LOCATION:Taubman Biomedical Science Research Building - Kahn Auditorium
CONTACT:
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20260226T120039
DTSTART;TZID=America/Detroit:20260310T160000
DTEND;TZID=America/Detroit:20260310T170000
SUMMARY:Lecture / Discussion:CPOD Winter/Spring 2026 Seminar Series: “Synthetic heart models for the study of cardiac development and disease”
DESCRIPTION:Aitor Aguirre\, Ph.D.\nAssociate Professor\nBiomedical Engineering\nMichigan State University
UID:145981-21898222@events.umich.edu
URL:https://events.umich.edu/event/145981
CLASS:PUBLIC
STATUS:CONFIRMED
CATEGORIES:biomedical engineering
LOCATION:Taubman Biomedical Science Research Building - ABC Seminar Rooms
CONTACT:
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20260219T101007
DTSTART;TZID=America/Detroit:20260312T150000
DTEND;TZID=America/Detroit:20260312T160000
SUMMARY:Workshop / Seminar:Biomedical Engineering (BME 500) Seminar Series
DESCRIPTION:Engineering immunotherapies for autoimmunity and cancer\n\nAbstract:\nEffective delivery of drugs to direct immune responses requires an understanding of biological barriers\, physicochemical properties of drug molecules\, formulation and transport in vivo.  Designing molecular structures that persist at the administration site or that promote drainage to regional lymphatic networks may enhance immune responses while sparing immune-related adverse events.  Here\, drug transport and local elimination mechanisms will be overviewed.  Then\, examples of molecular designs to direct drug delivery will be presented.  Autoimmune therapies were designed by our lab to promote the drainage of autoantigens to secondary lymphoid organs to treat autoimmune diseases.  Specifically\, the size and solubility of these molecular constructs were tuned to promote access to the lymphatic compartment and induce immune tolerance in mouse models of type 1 diabetes.  Our lab has also recently explored the design of immunostimulants that persist in tumor tissue after intratumoral/perilesional injection.  Intratumoral immunotherapy is proposed to work synergistically with checkpoint inhibitors making a nonresponsive ‘cold’ tumor ‘hot’ by recruiting and activating tumor infiltrating lymphocytes.  This approach can suffer from systemic immune-related adverse reactions\, however\, if enough immunostimulant escapes the site of administration.  Data on the use of electrostatic mechanisms to promote tumor retention will be presented.  These examples underscore the need for rational design of drug molecules or formulations based upon the route of delivery and biological barriers encountered.     \n\nBio:\nCory Berkland is the Mark and Becky Levin Professor in the Departments of Biomedical Engineering and Chemistry at Washington University in Saint Louis.  Previously\, he was the Solon E. Summerfield Professor in the Department of Pharmaceutical Chemistry and in the Department of Chemical Engineering at The University of Kansas.  He received MS and PhD degrees from the Department of Chemical and Biomolecular Engineering at the University of Illinois in Urbana-Champaign and a BS degree in Chemical Engineering from Iowa State University in Ames.  His lab studies pharmaceuticals and materials with an emphasis on molecular design and transport in the human body.  He is a co-founder of Orbis Biosciences (acquired by Adare Pharmaceuticals)\, Savara Pharmaceuticals (NASDAQ:SVRA)\, Bond Biosciences\, Kinimmune\, Axioforce\, and other start-ups.  He has served as a board member\, executive\, and fundraiser for these companies.
UID:145728-21897738@events.umich.edu
URL:https://events.umich.edu/event/145728
CLASS:PUBLIC
STATUS:CONFIRMED
CATEGORIES:biomedical engineering
LOCATION:Lurie Biomedical Engineering (formerly ATL) - 1130
CONTACT:
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20260310T135950
DTSTART;TZID=America/Detroit:20260317T160000
DTEND;TZID=America/Detroit:20260317T180000
SUMMARY:Lecture / Discussion:The Future of Health AI
DESCRIPTION:Join industry and startup leaders as they break down how AI is transforming healthcare now and where it’s headed next. Note: This event is for U-M students\, faculty\, and staff.\n\nMarch 17\, 2026\n4PM - 6PM\n​Ross School of Business\n701 Tappan Ave\, Ann Arbor\, MI 48109\, USA\nRobertson Auditorium\n\nRSVP here: https://myumi.ch/y1EmP\n\nEvent Schedule\n\n​4:00 PM\nArrival and Networking\n\n​4:30–6:00 PM\n​Welcome and Introduction\n\n​Perspectives on the Future of Health AI\nJim Mault\, MD\nFounder & Chairman\, BioIntelliSense\n​David Rhew\, MD\nChief Medical Officer\, Microsoft\n\n​Spotlight on U-M Health AI Startups\n\n​Fireside Conversation and Audience Q&A\n\n​6:00–6:30 PM\nNetworking Reception\n\n​This event is hosted by: \n​Pinkert Healthcare Accelerator (Zell Lurie Institute for Entrepreneurship)\n​Michigan Biomedical Venture Fund (Center for Entrepreneurship + Fast Forward Medical Innovation)\n\n​UM Partner Groups:\n​AI & Digital Health Innovation + e-HAIL\n​Michigan Medicine\n​Innovation Partnerships\n​Dept of Computational Medicine & Bioinformatics
UID:146126-21898419@events.umich.edu
URL:https://events.umich.edu/event/146126
CLASS:PUBLIC
STATUS:CONFIRMED
CATEGORIES:Biomedical Engineering
LOCATION:Ross School of Business - Robertson Auditorium
CONTACT:
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20260313T155924
DTSTART;TZID=America/Detroit:20260319T150000
DTEND;TZID=America/Detroit:20260319T160000
SUMMARY:Workshop / Seminar:Biomedical Engineering (BME 500) Seminar Series
DESCRIPTION:Patterned Biomaterials: New Tools to Probe and Control Complex Biological Systems\n\nAbstract:\nEngineered materials and molecular sensing tools are transforming how we study and control complex biological systems. Yet many technologies operate at a single scale—either manipulating cellular environments without molecular precision or profiling molecular signals without spatial or mechanical context. My lab addresses this challenge through chemical and materials innovation\, developing scalable platforms that integrate molecular design with quantitative analysis. We focus on two complementary directions: (1) physico-chemical design of soft interfaces with tunable nanoscale architecture and dynamic mechanics to probe and control material–biology interactions\, and (2) biomolecular sensing platforms that combine polymer chemistry\, optical or electrochemical detection\, and data-driven analysis for accessible diagnostics. In this talk\, I will highlight two representative efforts: nature-inspired nanopatterned coatings with dynamically tunable surface topography for long-term antibacterial activity\, and integrated bioanalytical sensing technologies for early\, point-of-care detection of sepsis.  \n\nBio:\nDr. Jouha Min is an Assistant Professor in the Department of Chemical Engineering at University of Michigan. She received her B.S. in Chemical Engineering from Cornell University in 2010 and her Ph.D. in Chemical Engineering from MIT\, where she was advised by Paula Hammond and Richard Braatz. She conducted her postdoctoral research with Ralph Weissleder at Harvard Medical School and Massachusetts General Hospital\, where she worked at the interface of engineering\, biology\, and clinical translation. Dr. Min’s research group applies core principles of chemical and biological engineering—including transport phenomena\, reaction kinetics\, materials synthesis\, and systems-level analysis—to develop new methodologies for probing and controlling material–biology interactions across three-dimensional space and time. Her work aims to establish a quantitative and mechanistic foundation for transformative advances in disease diagnosis\, treatment\, and prevention. She is the recipient of several honors\, including the NSF CAREER Award (2025)\, the NIH R35 MIRA Award (2025)\, and the V Foundation V Scholar Award (2023).
UID:146152-21898595@events.umich.edu
URL:https://events.umich.edu/event/146152
CLASS:PUBLIC
STATUS:CONFIRMED
CATEGORIES:biomedical engineering
LOCATION:Lurie Biomedical Engineering (formerly ATL) - 1130
CONTACT:
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20260212T124527
DTSTART;TZID=America/Detroit:20260323T130000
DTEND;TZID=America/Detroit:20260323T180000
SUMMARY:Conference / Symposium:Institutional Global Health Summit
DESCRIPTION:You're invited to the Institutional Global Health Summit\, an afternoon showcasing cutting-edge research\, dynamic debate\, and global perspectives on health for all.\n\nHosted by the Center for Global Health Equity\, this event brings together U-M faculty\, staff\, trainees\, students\, and global health leaders to showcase innovations addressing health for all through the dynamic exchange of ideas between local and international contexts.\n\n📅 Monday\, March 23\, 2026 | 1:00-6:00 PM\n📍 Rackham Amphitheatre\, University of Michigan\n🎟 Registration required (limited to members of the University of Michigan and Michigan Medicine community)\n\nEvent Highlights\n🔬 Research Lightning Talks | 1:15-3:05 PM\nFast-paced presentations from CGHE-supported Impact Scholars\, students\, and faculty across career stages \n \n🤖 Debate: The Role of AI in Global Equity | 3:15-4:15 PM\nFarhana Alarakhiya (Chief Data Innovation Officer\, Aga Khan University) and Bilal Butt\, PhD (Professor\, SEAS\; Senior Advisor\, CGHE) examine whether AI advances or undermines health equity\, moderated by Lou Edje\, MD \n \n🌍 Panel: Global Health in Transition | 4:15-5:00 PM\nMembers of CGHE's External Advisory Board share insights on navigating funding landscapes\, building partnerships\, and career pathways \n \n🎨 Poster Reception | 5:00-6:00 PM\nEngage with fellow researchers\, explore innovative projects\, and network with colleagues \n \nView the full program at https://myumi.ch/y15d4
UID:145260-21896960@events.umich.edu
URL:https://events.umich.edu/event/145260
CLASS:PUBLIC
STATUS:CONFIRMED
CATEGORIES:Biomedical Engineering
LOCATION:Rackham Graduate School (Horace H.) - Auditorium
CONTACT:
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20260313T152254
DTSTART;TZID=America/Detroit:20260324T150000
DTEND;TZID=America/Detroit:20260324T170000
SUMMARY:Workshop / Seminar:MICDE State of AI & the Future of Institutions
DESCRIPTION:MICDE State of AI & the Future of Institutions is a two-hour strategic conversation convened by the Michigan Institute for Computational Discovery and Engineering (MICDE). As AI rapidly reshapes research\, education\, governance\, and industry\, institutions face choices that will define their relevance for decades. This forum brings together faculty members and institutional leaders to examine where AI truly stands today and discuss how U-M must evolve to remain credible\, competitive\, and mission-driven in an AI-native era.
UID:146034-21898298@events.umich.edu
URL:https://events.umich.edu/event/146034
CLASS:PUBLIC
STATUS:CONFIRMED
CATEGORIES:Biomedical Engineering
LOCATION:Palmer Commons - Forum Hall
CONTACT:
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20260226T120252
DTSTART;TZID=America/Detroit:20260324T160000
DTEND;TZID=America/Detroit:20260324T170000
SUMMARY:Lecture / Discussion:CPOD Winter/Spring 2026 Seminar Series: \"Wnt you thought you knew about Wnt signaling\"
DESCRIPTION:Stephanie Grainger\, Ph.D.\nAssistant Professor\nCell Biology\nVan Andel Institute
UID:145982-21898223@events.umich.edu
URL:https://events.umich.edu/event/145982
CLASS:PUBLIC
STATUS:CONFIRMED
CATEGORIES:biomedical engineering
LOCATION:Taubman Biomedical Science Research Building - ABC Seminar Rooms
CONTACT:
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20260313T072550
DTSTART;TZID=America/Detroit:20260324T183000
DTEND;TZID=America/Detroit:20260324T193000
SUMMARY:Careers / Jobs:GEICO Corporate Information Sessions
DESCRIPTION:3/24/2026 | 6:30 pm | DOW 1018 (FOOD PROVIDED: Cottage Inn Pizza)\nMajors:  All Engineering Majors\nPositions: Full Time\, Intern\nDegrees: Bachelors\, Masters\n\nResumes Collected\nUS Citizenship or Permanent Resident\n\nGEICO (Government Employees Insurance Company) is a leading American auto insurer\, ranking as the second-largest in the U.S. A Berkshire Hathaway subsidiary founded in 1936\, it specializes in direct-to-consumer private passenger auto insurance\, offering policies online and by phone. GEICO also covers motorcycles\, RVs\, homeowners\, and renters.
UID:146554-21899265@events.umich.edu
URL:https://events.umich.edu/event/146554
CLASS:PUBLIC
STATUS:CONFIRMED
CATEGORIES:Biomedical Engineering
LOCATION:Chemistry Dow Lab - 1018
CONTACT:
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20260220T102635
DTSTART;TZID=America/Detroit:20260326T100000
DTEND;TZID=America/Detroit:20260326T114500
SUMMARY:Workshop / Seminar:SCSAP Special Research Seminar and Town Hall Event
DESCRIPTION:SCSAP Special Research Seminar and Town Hall Discussion Event\nDate: Thursday\, March 26\, 2026\nLocation: Live In-Person Only (Will not be streamed or recorded)\n NCRC Building 18\, Dining Hall\nFREE TO ALL\, Everyone is Welcome\, \nLite Refreshments provided\n\nFEATURING: Dr. Aviv Regev\, Executive Vice President and Head of Genentech Research and Early Development and Executive Committee of the Human Cell Atlas\n\n*PLEASE REGISTER FOR THIS EVENT*\n\nTwo Events of Interest: \n\n10:00–10:45 AM- Talk Title: “Towards Unified Cell and Tissue Oracles”- Featuring Dr. Regev- Hosted by SCSAP \n\n11:00–11:45 AM Town Hall Discussion Featuring Dr. Regev and an invited faculty panel – event will cover several topics such as the future of single cell spatial-omics\, strategies for productive collaboration\, AI development of new drugs.
UID:145768-21897796@events.umich.edu
URL:https://events.umich.edu/event/145768
CLASS:PUBLIC
STATUS:CONFIRMED
CATEGORIES:Biomedical Engineering
LOCATION:North Campus Research Complex Building 18 - Dining Hall
CONTACT:
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20260129T164237
DTSTART;TZID=America/Detroit:20260326T120000
DTEND;TZID=America/Detroit:20260326T133000
SUMMARY:Livestream / Virtual:Building Industry Partnerships Webinar Series
DESCRIPTION:Federal funding trends\, including from NSF\, DOE and ARPA agencies\, indicate increasing interest in translational research – supporting the pathways for fundamental discoveries to have broader societal\, economic or public impact. New funding programs might require researchers to demonstrate their research impact at the proposal stage through established partnerships with companies that signal market interest or investment\, formal commitments like licensing agreements\, and/or evidence of technology readiness levels. Researchers who build these industry partnerships in advance will have a critical edge in a competitive funding landscape.\n\nThe Office of Research Development will host a webinar series for U-M researchers that explains why and how to build industry partnerships that advance mutual R&D goals. Webinars will take place noon-1:30 pm each day\; calendar invites will be sent upon registration. \n\nFebruary 25: Discovery to Innovation - Gain a practical framework for deciding when to engage industry\, how to demonstrate impact credibly and which funding mechanisms align with research maturing and scholarly goals.\nMarch 26: Industry Engagement for Faculty: From Early Signals to Funded Partnerships - Learn meaningful engagement strategies across the research lifecycle\, emphasizing alignment with academic incentives\, research integrity and appropriate funding mechanisms. \nApril 9: Building Industry Partnerships that Last: Whom to Talk to\, What to Ask - Learn how to identify the right industry counterparts\, structure early conversations to surface meaningful research and translational opportunities and set expectations that can evolve into sustained collaboration.   \nContact RD-Support@umich.edu with questions.
UID:144802-21895960@events.umich.edu
URL:https://events.umich.edu/event/144802
CLASS:PUBLIC
STATUS:CONFIRMED
CATEGORIES:Biomedical Engineering
LOCATION:Off Campus Location
CONTACT:
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20260114T145000
DTSTART;TZID=America/Detroit:20260408T160000
DTEND;TZID=America/Detroit:20260408T170000
SUMMARY:Workshop / Seminar:CCMB/DCMB Weekly Seminar Series featuring Ting Wang\, PhD (Professor of Medicine and Head\, Department of Genetics WashU Medicine)
DESCRIPTION:The CCMB Seminar Series (Sponsored by DCMB) is held at Medical Science 2\, 2710 Furstenberg\, each Wednesday\, at 4:00 pm EST\, on bioinformatics-related topics.Each seminar is presented by an invited guest speaker. These seminars are live-streamed on Zoom.
UID:143699-21893661@events.umich.edu
URL:https://events.umich.edu/event/143699
CLASS:PUBLIC
STATUS:CONFIRMED
CATEGORIES:Biomedical Engineering
LOCATION:Medical Science Unit I - 4B700
CONTACT:
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20260129T164237
DTSTART;TZID=America/Detroit:20260409T120000
DTEND;TZID=America/Detroit:20260409T133000
SUMMARY:Livestream / Virtual:Building Industry Partnerships Webinar Series
DESCRIPTION:Federal funding trends\, including from NSF\, DOE and ARPA agencies\, indicate increasing interest in translational research – supporting the pathways for fundamental discoveries to have broader societal\, economic or public impact. New funding programs might require researchers to demonstrate their research impact at the proposal stage through established partnerships with companies that signal market interest or investment\, formal commitments like licensing agreements\, and/or evidence of technology readiness levels. Researchers who build these industry partnerships in advance will have a critical edge in a competitive funding landscape.\n\nThe Office of Research Development will host a webinar series for U-M researchers that explains why and how to build industry partnerships that advance mutual R&D goals. Webinars will take place noon-1:30 pm each day\; calendar invites will be sent upon registration. \n\nFebruary 25: Discovery to Innovation - Gain a practical framework for deciding when to engage industry\, how to demonstrate impact credibly and which funding mechanisms align with research maturing and scholarly goals.\nMarch 26: Industry Engagement for Faculty: From Early Signals to Funded Partnerships - Learn meaningful engagement strategies across the research lifecycle\, emphasizing alignment with academic incentives\, research integrity and appropriate funding mechanisms. \nApril 9: Building Industry Partnerships that Last: Whom to Talk to\, What to Ask - Learn how to identify the right industry counterparts\, structure early conversations to surface meaningful research and translational opportunities and set expectations that can evolve into sustained collaboration.   \nContact RD-Support@umich.edu with questions.
UID:144802-21895961@events.umich.edu
URL:https://events.umich.edu/event/144802
CLASS:PUBLIC
STATUS:CONFIRMED
CATEGORIES:Biomedical Engineering
LOCATION:Off Campus Location
CONTACT:
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20260226T120509
DTSTART;TZID=America/Detroit:20260414T160000
DTEND;TZID=America/Detroit:20260414T170000
SUMMARY:Lecture / Discussion:CPOD Winter/Spring 2026 Seminar Series: \"How life finds a way: resilience in mammalian embryogenesis\"
DESCRIPTION:Sarah Bowling\, Ph.D.\nAssistant Professor\nDevelopmental Biology\nStanford University
UID:145983-21898224@events.umich.edu
URL:https://events.umich.edu/event/145983
CLASS:PUBLIC
STATUS:CONFIRMED
CATEGORIES:biomedical engineering
LOCATION:Taubman Biomedical Science Research Building - ABC Seminar Rooms
CONTACT:
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20260226T120735
DTSTART;TZID=America/Detroit:20260428T160000
DTEND;TZID=America/Detroit:20260428T170000
SUMMARY:Lecture / Discussion:CPOD Winter/Spring 2026 Seminar Series: \"From stillness to motion: Spatiotemporal dynamics of lung stem cells in injury and repair”
DESCRIPTION:Maurizio Chioccioli\, Ph.D.\nAssistant Professor\nGenetics & Comparative Medicine\nYale University
UID:145984-21898225@events.umich.edu
URL:https://events.umich.edu/event/145984
CLASS:PUBLIC
STATUS:CONFIRMED
CATEGORIES:biomedical engineering
LOCATION:Taubman Biomedical Science Research Building - ABC Seminar Rooms
CONTACT:
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20260226T120939
DTSTART;TZID=America/Detroit:20260519T160000
DTEND;TZID=America/Detroit:20260519T170000
SUMMARY:Lecture / Discussion:CPOD Winter/Spring 2026 Seminar Series: \"Engineering next-generation intrabodies for monitoring the dynamics of proteins and their modifications in living cells\"
DESCRIPTION:Timothy Stasevich\, Ph.D.\nAssociate Professor\nBiochemistry & Molecular Biology\nColorado State University
UID:145985-21898226@events.umich.edu
URL:https://events.umich.edu/event/145985
CLASS:PUBLIC
STATUS:CONFIRMED
CATEGORIES:biomedical engineering
LOCATION:Taubman Biomedical Science Research Building - ABC Seminar Rooms
CONTACT:
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20260310T095151
DTSTART;TZID=America/Detroit:20260605T080000
DTEND;TZID=America/Detroit:20260605T170000
SUMMARY:Conference / Symposium:TEAM 50th Anniversary
DESCRIPTION:NIH T32 Training Program \nTissue Engineering at Michigan \n\nSymposium: \nFriday\, June 5\, 2026\n8:00-5:00 PM\nBiomedical Science Research Building
UID:146394-21899038@events.umich.edu
URL:https://events.umich.edu/event/146394
CLASS:PUBLIC
STATUS:CONFIRMED
CATEGORIES:Biomedical Engineering
LOCATION:Taubman Biomedical Science Research Building - Auditorium
CONTACT:
END:VEVENT
END:VCALENDAR